One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The role and participation of immune cells in the endometrial tumor microenvironment
Debasish Kumar Dey, Danielle Krause, Rajani Rai, Swati Choudhary, Lauren E. Dockery, Vishal Chandra
doi : 10.1016/j.pharmthera.2023.108526
Volume 251, November 2023, 108526
Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease
Clavia Ruth Wooton-Kee
doi : 10.1016/j.pharmthera.2023.108529
Volume 251, November 2023, 108529
Modulating glucocorticoid receptor actions in physiology and pathology: Insights from coregulators
Lina Fadel a,1 , Marija Dacic b,c,1 , Vlera Fonda a , Baila A. Sokolsky b,d , Fabiana Quagliarini a , Inez Rogatsky b,d,??, N. Henriette Uhlenhaut
doi : 10.1016/j.pharmthera.2023.108531
Volume 251, November 2023, 108531
Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases
Pengfei Xu a,b , Xinran Cai a , Xiuchen Guan c , Wen Xie
doi : 10.1016/j.pharmthera.2023.108540
Volume 251, November 2023, 108540
Presynaptic glutamate receptors in nociception
Rou-Gang Xie a,?, Guang-Yin Xu b , Sheng-Xi Wu a,?, Ceng Luo
doi : 10.1016/j.pharmthera.2023.108539
Volume 251, November 2023, 108539
Signaling pathways in brain ischemia: Mechanisms and therapeutic implications
Wen Lin a,1 , Xiang-Yu Zhao a,1 , Jia-wen Cheng b , Li-tao Li d , Quan Jiang e , Yi-Xuan Zhang a,c,?, Feng Han
doi : 10.1016/j.pharmthera.2023.108541
Volume 251, November 2023, 108541
Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons
Maxime Thouaye a , Ipek Yalcin
doi : 10.1016/j.pharmthera.2023.108546
Volume 251, November 2023, 108546
Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease: Challenges and research opportunities
Wiramon Rungratanawanich a , Jacob W. Ballway a , Xin Wang b , Kyoung-Jae Won c , James P. Hardwick d,?, Byoung-Joon Song
doi : 10.1016/j.pharmthera.2023.108547
Volume 251, November 2023, 108547
Severe hypertriglyceridemia: Existing and emerging therapies
Waqas A. Malick a , Ron Do b , Robert S. Rosenson
doi : 10.1016/j.pharmthera.2023.108544
Volume 251, November 2023, 108544
Boron in cancer therapeutics: An overview
Swanand Kulkarni 1 , Dyuti Bhandary 1 , Yogesh Singh, Vikramdeep Monga, Suresh Thareja
doi : 10.1016/j.pharmthera.2023.108548
Volume 251, November 2023, 108548
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
doi : 10.1016/j.pharmthera.2023.108545
Volume 251, November 2023, 108545
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Simon Kloock a , Christian G. Ziegler a,b , Ulrich Dischinger
doi : 10.1016/j.pharmthera.2023.108549
Volume 251, November 2023, 108549
